Delivery Order SPE2DB22D2211-SPE2DB24FNTQ2

Award Date 6/19/24
Potential Completion Date 6/20/24
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,087.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a pharmaceutical product, to support federal government healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,080.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a 17 ml medication. The award is a firm fixed-price delivery order with a completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,143.06 firm fixed price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award, valued at $5,540.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ferumoxytol, a 510 mg/17 ml vial medication, with a completion date of July 13, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 ml vials of the pharmaceutical drug ferumoxytol, valued at $6,484.80. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,565.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FKJVM) for the supply of Ferumoxytol, a 510 mg/17 ml vial medication, with a performance period extending through April 2025. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award and holds a significant Indefinite...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $4,303.98. The award is for the delivery of 17 mL vials of the pharmaceutical product Ferumoxytol, which is used for the treatment of iron deficiency anemia. The DLA Troop Support Medical IDC is a $999,999,999 contract that provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,969.60, is for the supply of Ferumoxytol 510 mg/17 ml vials, a medical product used in healthcare settings. The contract has an ultimate completion date of March 28, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of Ferumoxytol 510 mg/17 ml vial, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,108.26 and a completion date of June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNTQ2
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,480.29 firm fixed-price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials to support federal healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This IDC, which runs through November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award was not designated with any set-aside requirements, indicating open competition. No subcontractor information was provided.

Generated 5/17/25, 9:56 AM